Narcolepsy

  • Sebastiaan Overeem
    Correspondence
    Corresponding author. Department of Neurology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
    Affiliations
    Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Nijmegen Medical Centre, Reinier Postlaan 4, PO Box 9101, 6500 HB Nijmegen, The Netherlands

    Sleep Medicine Centre ‘Kempenhaeghe’, Sterkselseweg 65, 5590 AB Heeze, The Netherlands
    Search for articles by this author
  • Paul Reading
    Affiliations
    Department of Neurology, The James Cook University Hospital, Marton Road, Middlesbrough TS4 3BW, UK
    Search for articles by this author
  • Claudio L. Bassetti
    Affiliations
    Department of Neurology, University Hospital (Inselspital), Freiburgstrasse 1, Bern 3010, Switzerland

    Neurocenter of Southern Switzerland, Via Tesserete 46, 6903 Lugano, Switzerland
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mignot E.
        A hundred years of narcolepsy research.
        Arch Ital Biol. 2001; 139: 207-220
        • Dauvilliers Y.
        • Arnulf I.
        • Mignot E.
        Narcolepsy with cataplexy.
        Lancet. 2007; 369: 499-511
        • Sturzenegger C.
        • Bassetti C.
        The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
        J Sleep Res. 2004; 13: 395-406
        • Nishino S.
        Hypothalamus, hypocretins/orexin, and vigilance control.
        Handb Clin Neurol. 2011; 99: 765-782
        • Dodel R.
        • Peter H.
        • Spottke A.
        • et al.
        Health-related quality of life in patients with narcolepsy.
        Sleep Med. 2007; 8: 733-741
        • Vignatelli L.
        • Plazzi G.
        • Peschechera F.
        • et al.
        A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy.
        Sleep Med. 2011; 12: 19-23
        • Westphal C.
        Eigenthümliche mit Einschlafen verbundene Anfälle.
        Arch Psychiatr Nervenkr. 1877; 7: 631-635
        • Gélineau J.B.
        De la narcolepsie.
        Gaz Hôp (Paris). 1880; 53: 626-628
        • Overeem S.
        • Mignot E.
        • van Dijk J.G.
        • et al.
        Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.
        J Clin Neurophysiol. 2001; 18: 78-105
        • Yoss R.E.
        • Daly D.D.
        Criteria for the diagnosis of the narcoleptic syndrome.
        Proc Staff Meet Mayo Clin. 1957; 32: 320-328
        • Kok S.W.
        • Overeem S.
        • Visscher T.L.
        • et al.
        Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity.
        Obes Res. 2003; 11: 1147-1154
        • Fortuyn H.A.
        • Lappenschaar M.A.
        • Furer J.W.
        • et al.
        Anxiety and mood disorders in narcolepsy: a case-control study.
        Gen Hosp Psychiatry. 2010; 32: 49-56
        • Fortuyn H.A.
        • Swinkels S.
        • Buitelaar J.
        • et al.
        High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study.
        Sleep. 2008; 31: 335-341
        • Longstreth Jr., W.T.
        • Koepsell T.D.
        • Ton T.G.
        • et al.
        The epidemiology of narcolepsy.
        Sleep. 2007; 30: 13-26
        • Ohayon M.M.
        • Priest R.G.
        • Zulley J.
        • et al.
        Prevalence of narcolepsy symptomatology and diagnosis in the European general population.
        Neurology. 2002; 58: 1826-1833
        • Hublin C.
        • Kaprio J.
        • Partinen M.
        • et al.
        The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort.
        Ann Neurol. 1994; 35: 709-716
        • Lavie P.
        • Peled R.
        Narcolepsy is a rare disease in Israel.
        Sleep. 1987; 10: 608-609
        • Honda Y.
        Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city.
        Sleep Res. 1979; 8: 191
        • Silber M.H.
        • Krahn L.E.
        • Olson E.J.
        • et al.
        The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study.
        Sleep. 2002; 25: 197-202
        • Morrish E.
        • King M.A.
        • Smith I.E.
        • et al.
        Factors associated with a delay in the diagnosis of narcolepsy.
        Sleep Med. 2004; 5: 37-41
        • Dauvilliers Y.
        • Montplaisir J.
        • Molinari N.
        • et al.
        Age at onset of narcolepsy in two large populations of patients in France and Quebec.
        Neurology. 2001; 57: 2029-2033
        • Plazzi G.
        • Pizza F.
        • Palaia V.
        • et al.
        Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.
        Brain. 2011; 134: 3480-3492
        • Ohayon M.M.
        • Ferini-Strambi L.
        • Plazzi G.
        • et al.
        How age influences the expression of narcolepsy.
        J Psychosom Res. 2005; 59: 399-405
        • Mitler M.M.
        • Boysen B.G.
        • Campbell L.
        • et al.
        Narcolepsy-cataplexy in a female dog.
        Exp Neurol. 1974; 45: 332-340
        • Foutz A.S.
        • Mitler M.M.
        • Cavalli-Sforza L.L.
        • et al.
        Genetic factors in canine narcolepsy.
        Sleep. 1979; 1: 413-421
        • Lin L.
        • Faraco J.
        • Li R.
        • et al.
        The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.
        Cell. 1999; 98: 365-376
        • Chemelli R.M.
        • Willie J.T.
        • Sinton C.M.
        • et al.
        Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
        Cell. 1999; 98: 437-451
        • Nishino S.
        • Mignot E.
        Pharmacological aspects of human and canine narcolepsy.
        Prog Neurobiol. 1997; 52: 27-78
        • De La Herran-Arita A.K.
        • Zomosa-Signoret V.C.
        • Millan-Aldaco D.A.
        • et al.
        Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.
        Neuroscience. 2011; 183: 134-143
        • Gerashchenko D.
        • Kohls M.D.
        • Greco M.
        • et al.
        Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
        J Neurosci. 2001; 21: 7273-7283
        • Mieda M.
        • Hasegawa E.
        • Kisanuki Y.Y.
        • et al.
        Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.
        J Neurosci. 2011; 31: 6518-6526
        • Willie J.T.
        • Chemelli R.M.
        • Sinton C.M.
        • et al.
        Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes.
        Neuron. 2003; 38: 715-730
        • Hara J.
        • Beuckmann C.T.
        • Nambu T.
        • et al.
        Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.
        Neuron. 2001; 30: 345-354
        • Scammell T.E.
        • Willie J.T.
        • Guilleminault C.
        • et al.
        A consensus definition of cataplexy in mouse models of narcolepsy.
        Sleep. 2009; 32: 111-116
        • Nishino S.
        • Ripley B.
        • Overeem S.
        • et al.
        Hypocretin (orexin) deficiency in human narcolepsy.
        Lancet. 2000; 355: 39-40
        • Nishino S.
        • Ripley B.
        • Overeem S.
        • et al.
        Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.
        Ann Neurol. 2001; 50: 381-388
        • Bassetti C.
        • Gugger M.
        • Bischof M.
        • et al.
        The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
        Sleep Med. 2003; 4: 7-12
        • Kanbayashi T.
        • Inoue Y.
        • Chiba S.
        • et al.
        CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
        J Sleep Res. 2002; 11: 91-93
        • Krahn L.E.
        • Pankratz V.S.
        • Oliver L.
        • et al.
        Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
        Sleep. 2002; 25: 733-736
        • Mignot E.
        • Lammers G.J.
        • Ripley B.
        • et al.
        The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
        Arch Neurol. 2002; 59: 1553-1562
        • Ripley B.
        • Overeem S.
        • Fujiki N.
        • et al.
        CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.
        Neurology. 2001; 57: 2253-2258
        • Nishino S.
        • Kanbayashi T.
        Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
        Sleep Med Rev. 2005; 9: 269-310
        • Baumann C.R.
        • Stocker R.
        • Imhof H.G.
        • et al.
        Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
        Neurology. 2005; 65: 147-149
        • Kanbayashi T.
        • Ishiguro H.
        • Aizawa R.
        • et al.
        Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barre syndrome.
        Psychiatry Clin Neurosci. 2002; 56: 273-274
        • Nishino S.
        • Kanbayashi T.
        • Fujiki N.
        • et al.
        CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies.
        Neurology. 2003; 61: 823-825
        • Overeem S.
        • Dalmau J.
        • Bataller L.
        • et al.
        Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.
        Neurology. 2004; 62: 138-140
        • Peyron C.
        • Faraco J.
        • Rogers W.
        • et al.
        A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.
        Nat Med. 2000; 6: 991-997
        • Thannickal T.C.
        • Moore R.Y.
        • Nienhuis R.
        • et al.
        Reduced number of hypocretin neurons in human narcolepsy.
        Neuron. 2000; 27: 469-474
        • Thannickal T.C.
        • Siegel J.M.
        • Nienhuis R.
        • et al.
        Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.
        Brain Pathol. 2003; 13: 340-351
        • Blouin A.M.
        • Thannickal T.C.
        • Worley P.F.
        • et al.
        Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
        Neurology. 2005; 65: 1189-1192
        • Crocker A.
        • Espana R.A.
        • Papadopoulou M.
        • et al.
        Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
        Neurology. 2005; 65: 1184-1188
        • Chabas D.
        • Taheri S.
        • Renier C.
        • et al.
        The genetics of narcolepsy.
        Annu Rev Genomics Hum Genet. 2003; 4: 459-483
        • Mignot E.
        Genetic and familial aspects of narcolepsy.
        Neurology. 1998; 50: S16-S22
        • Dauvilliers Y.
        • Maret S.
        • Bassetti C.
        • et al.
        A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.
        Neurology. 2004; 62: 2137-2138
        • Honda M.
        • Honda Y.
        • Uchida S.
        • et al.
        Monozygotic twins incompletely concordant for narcolepsy.
        Biol Psychiatry. 2001; 49: 943-947
        • Khatami R.
        • Maret S.
        • Werth E.
        • et al.
        Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
        Lancet. 2004; 363: 1199-1200
        • Partinen M.
        • Hublin C.
        • Kaprio J.
        • et al.
        Twin studies in narcolepsy.
        Sleep. 1994; 17: S13-S16
        • Juji T.
        • Satake M.
        • Honda Y.
        • et al.
        HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.
        Tissue Antigens. 1984; 24: 316-319
        • Mignot E.
        • Hayduk R.
        • Black J.
        • et al.
        HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
        Sleep. 1997; 20: 1012-1020
        • Mignot E.
        • Kimura A.
        • Lattermann A.
        • et al.
        Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.
        Tissue Antigens. 1997; 49: 329-341
        • Hor H.
        • Kutalik Z.
        • Dauvilliers Y.
        • et al.
        Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.
        Nat Genet. 2010; 42: 786-789
        • Hallmayer J.
        • Faraco J.
        • Lin L.
        • et al.
        Narcolepsy is strongly associated with the T-cell receptor alpha locus.
        Nat Genet. 2009; 41: 708-711
        • Hohjoh H.
        • Nakayama T.
        • Ohashi J.
        • et al.
        Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy.
        Tissue Antigens. 1999; 54: 138-145
        • Hohjoh H.
        • Terada N.
        • Kawashima M.
        • et al.
        Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy.
        Tissue Antigens. 2000; 56: 446-448
        • Kornum B.R.
        • Kawashima M.
        • Faraco J.
        • et al.
        Common variants in P2RY11 are associated with narcolepsy.
        Nat Genet. 2011; 43: 66-71
        • Overeem S.
        • Black 3rd, J.L.
        • Lammers G.J.
        Narcolepsy: immunological aspects.
        Sleep Med Rev. 2008; 12: 95-107
        • Fontana A.
        • Gast H.
        • Reith W.
        • et al.
        Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?.
        Brain. 2010; 133: 1300-1311
        • Scammell T.E.
        The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy.
        Sleep. 2006; 29: 601-602
        • Overeem S.
        • Verschuuren J.J.
        • Fronczek R.
        • et al.
        Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.
        J Neuroimmunol. 2006; 174: 187-191
        • Black 3rd, J.L.
        • Krahn L.E.
        • Pankratz V.S.
        • et al.
        Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.
        Sleep. 2002; 25: 719-723
        • Black 3rd, J.L.
        • Silber M.H.
        • Krahn L.E.
        • et al.
        Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
        Biol Psychiatry. 2005; 58: 504-509
        • Black 3rd, J.L.
        • Avula R.K.
        • Walker D.L.
        • et al.
        HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract.
        Sleep. 2005; 28: 1191-1192
        • Cvetkovic-Lopes V.
        • Bayer L.
        • Dorsaz S.
        • et al.
        Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
        J Clin Invest. 2010; 120: 713-719
        • Kawashima M.
        • Lin L.
        • Tanaka S.
        • et al.
        Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.
        Sleep. 2010; 33: 869-874
        • Toyoda H.
        • Tanaka S.
        • Miyagawa T.
        • et al.
        Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy.
        Sleep. 2010; 33: 875-878
        • Aran A.
        • Lin L.
        • Nevsimalova S.
        • et al.
        Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.
        Sleep. 2009; 32: 979-983
        • Longstreth Jr., W.T.
        • Ton T.G.
        • Koepsell T.D.
        Narcolepsy and streptococcal infections.
        Sleep. 2009; 32: 1548
        • Dauvilliers Y.
        Follow-up of four narcolepsy patients treated with intravenous immunoglobulins.
        Ann Neurol. 2006; 60: 153
        • Dauvilliers Y.
        • Carlander B.
        • Rivier F.
        • et al.
        Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.
        Ann Neurol. 2004; 56: 905-908
        • Lecendreux M.
        • Maret S.
        • Bassetti C.
        • et al.
        Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.
        J Sleep Res. 2003; 12: 347-348
        • Fronczek R.
        • Verschuuren J.
        • Lammers G.J.
        Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy.
        J Neurol. 2007; 254: 1607-1608
        • Plazzi G.
        • Poli F.
        • Franceschini C.
        • et al.
        Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.
        J Neurol. 2008; 255: 1549-1554
        • Valko P.O.
        • Khatami R.
        • Baumann C.R.
        • et al.
        No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.
        J Neurol. 2008; 255: 1900-1903
        • Bardage C.
        • Persson I.
        • Ortqvist A.
        • et al.
        Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
        BMJ. 2011; 343: d5956
        • Dauvilliers Y.
        • Montplaisir J.
        • Cochen V.
        • et al.
        Post-H1N1 narcolepsy-cataplexy.
        Sleep. 2010; 33: 1428-1430
        • Zarocostas J.
        WHO backs further probes into possible link between H1N1 vaccine and narcolepsy in children.
        BMJ. 2011; 342: d909
        • Han F.
        • Lin L.
        • Warby S.C.
        • et al.
        Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
        Ann Neurol. 2011; 70: 410-417
        • Bayer L.
        • Eggermann E.
        • Serafin M.
        • et al.
        Orexins (hypocretins) directly excite tuberomammillary neurons.
        Eur J Neurosci. 2001; 14: 1571-1575
        • Peyron C.
        • Tighe D.K.
        • van den Pol A.N.
        • et al.
        Neurons containing hypocretin (orexin) project to multiple neuronal systems.
        J Neurosci. 1998; 18: 9996-10015
        • Saper C.B.
        • Chou T.C.
        • Scammell T.E.
        The sleep switch: hypothalamic control of sleep and wakefulness.
        Trends Neurosci. 2001; 24: 726-731
        • Diniz Behn C.G.
        • Klerman E.B.
        • Mochizuki T.
        • et al.
        Abnormal sleep/wake dynamics in orexin knockout mice.
        Sleep. 2010; 33: 297-306
        • Mochizuki T.
        • Crocker A.
        • McCormack S.
        • et al.
        Behavioral state instability in orexin knock-out mice.
        J Neurosci. 2004; 24: 6291-6300
        • Broughton R.
        • Dunham W.
        • Newman J.
        • et al.
        Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls.
        Electroencephalogr Clin Neurophysiol. 1988; 70: 473-481
        • Lammers G.J.
        • Overeem S.
        • Tijssen M.A.
        • et al.
        Effects of startle and laughter in cataplectic subjects: a neurophysiological study between attacks.
        Clin Neurophysiol. 2000; 111: 1276-1281
        • Overeem S.
        • Lammers G.J.
        • van Dijk J.G.
        Weak with laughter.
        Lancet. 1999; 354: 838
        • Overeem S.
        • Reijntjes R.
        • Huyser W.
        • et al.
        Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia.
        J Sleep Res. 2004; 13: 257-264
        • Overeem S.
        • Lammers G.J.
        • van Dijk J.G.
        Cataplexy: ‘tonic immobility’ rather than 'REM-sleep atonia'?.
        Sleep Med. 2002; 3: 471-477
        • Mileykovskiy B.Y.
        • Kiyashchenko L.I.
        • Siegel J.M.
        Behavioral correlates of activity in identified hypocretin/orexin neurons.
        Neuron. 2005; 46: 787-798
        • Hishikawa Y.
        • Shimizu T.
        Physiology of REM sleep, cataplexy, and sleep paralysis.
        Adv Neurol. 1995; 67: 245-271
        • Poryazova R.
        • Schnepf B.
        • Werth E.
        • et al.
        Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.
        Sleep. 2009; 32: 607-613
        • Schwartz S.
        • Ponz A.
        • Poryazova R.
        • et al.
        Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy.
        Brain. 2008; 131: 514-522
        • Plazzi G.
        • Serra L.
        • Ferri R.
        Nocturnal aspects of narcolepsy with cataplexy.
        Sleep Med Rev. 2008; 12: 109-128
        • Mullington J.
        • Broughton R.
        Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy.
        Sleep. 1993; 16: 444-456
        • American Academy of Sleep Medicine
        The International Classification of Sleep Disorders: diagnostic and coding manual.
        2nd edition. AASM, Chicago2005
        • Anic-Labat S.
        • Guilleminault C.
        • Kraemer H.C.
        • et al.
        Validation of a cataplexy questionnaire in 983 sleep-disorders patients.
        Sleep. 1999; 22: 77-87
        • Guilleminault C.
        • Gelb M.
        Clinical aspects and features of cataplexy.
        Adv Neurol. 1995; 67: 65-77
        • Overeem S.
        • van Nues S.J.
        • van der Zande W.L.
        • et al.
        The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.
        Sleep Med. 2011; 12: 12-18
        • Gelb M.
        • Guilleminault C.
        • Kraemer H.
        • et al.
        Stability of cataplexy over several months–information for the design of therapeutic trials.
        Sleep. 1994; 17: 265-273
        • Poryazova R.
        • Siccoli M.
        • Werth E.
        • et al.
        Unusually prolonged rebound cataplexy after withdrawal of fluoxetine.
        Neurology. 2005; 65: 967-968
        • Serra L.
        • Montagna P.
        • Mignot E.
        • et al.
        Cataplexy features in childhood narcolepsy.
        Mov Disord. 2008; 23: 858-865
        • Dhondt K.
        • Verhelst H.
        • Pevernagie D.
        • et al.
        Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma.
        Sleep Med. 2009; 10: 797-798
        • Peraita-Adrados R.
        • Garcia-Penas J.J.
        • Ruiz-Falco L.
        • et al.
        Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.
        Sleep Med. 2011; 12: 24-27
        • Fortuyn H.A.
        • Lappenschaar G.A.
        • Nienhuis F.J.
        • et al.
        Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia.
        Gen Hosp Psychiatry. 2009; 31: 146-154
        • Douglass A.B.
        • Hays P.
        • Pazderka F.
        • et al.
        Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy.
        J Nerv Ment Dis. 1991; 179 ([discussion: 8]): 12-17
        • Montplaisir J.
        • Billiard M.
        • Takahashi S.
        • et al.
        Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption.
        Biol Psychiatry. 1978; 13: 73-89
        • Montplaisir J.
        • Godbout R.
        Nocturnal sleep of narcoleptic patients: revisited.
        Sleep. 1986; 9: 159-161
        • Broughton R.
        • Dunham W.
        • Weisskopf M.
        • et al.
        Night sleep does not predict day sleep in narcolepsy.
        Electroencephalogr Clin Neurophysiol. 1994; 91: 67-70
        • Nightingale S.
        • Orgill J.C.
        • Ebrahim I.O.
        • et al.
        The association between narcolepsy and REM behavior disorder (RBD).
        Sleep Med. 2005; 6: 253-258
        • Schenck C.H.
        • Mahowald M.W.
        Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder.
        Ann Neurol. 1992; 32: 3-10
        • Fronczek R.
        • Middelkoop H.A.
        • van Dijk J.G.
        • et al.
        Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART).
        Sleep. 2006; 29: 187-191
        • Aguirre M.
        • Broughton R.
        • Stuss D.
        Does memory impairment exist in narcolepsy-cataplexy?.
        J Clin Exp Neuropsychol. 1985; 7: 14-24
        • Daniels L.E.
        Narcolepsy.
        Medicine. 1934; 13: 1-122
        • Dahmen N.
        • Bierbrauer J.
        • Kasten M.
        Increased prevalence of obesity in narcoleptic patients and relatives.
        Eur Arch Psychiatry Clin Neurosci. 2001; 251: 85-89
        • Schuld A.
        • Hebebrand J.
        • Geller F.
        • et al.
        Increased body-mass index in patients with narcolepsy.
        Lancet. 2000; 355: 1274-1275
        • Lammers G.J.
        • Pijl H.
        • Iestra J.
        • et al.
        Spontaneous food choice in narcolepsy.
        Sleep. 1996; 19: 75-76
        • Arnulf I.
        • Lin L.
        • Zhang J.
        • et al.
        CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?.
        Sleep. 2006; 29: 1017-1024
        • Dahmen N.
        • Engel A.
        • Helfrich J.
        • et al.
        Peripheral leptin levels in narcoleptic patients.
        Diabetes Technol Ther. 2007; 9: 348-353
        • Kok S.W.
        • Meinders A.E.
        • Overeem S.
        • et al.
        Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans.
        J Clin Endocrinol Metab. 2002; 87: 805-809
        • Overeem S.
        • Kok S.W.
        • Lammers G.J.
        • et al.
        Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events.
        Am J Physiol Endocrinol Metab. 2003; 284: E641-E647
        • Schuld A.
        • Blum W.F.
        • Uhr M.
        • et al.
        Reduced leptin levels in human narcolepsy.
        Neuroendocrinology. 2000; 72: 195-198
        • Dauvilliers Y.
        • Paquereau J.
        • Bastuji H.
        • et al.
        Psychological health in central hypersomnias: the French Harmony study.
        J Neurol Neurosurg Psychiatry. 2009; 80: 636-641
        • Kales A.
        • Soldatos C.R.
        • Bixler E.O.
        • et al.
        Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology.
        Arch Neurol. 1982; 39: 169-171
        • Vourdas A.
        • Shneerson J.M.
        • Gregory C.A.
        • et al.
        Narcolepsy and psychopathology: is there an association?.
        Sleep Med. 2002; 3: 353-360
        • Ponz A.
        • Khatami R.
        • Poryazova R.
        • et al.
        Reduced amygdala activity during aversive conditioning in human narcolepsy.
        Ann Neurol. 2010; 67: 394-398
        • Droogleever Fortuyn H.A.
        • Fronczek R.
        • Smitshoek M.
        • et al.
        Severe fatigue in narcolepsy with cataplexy.
        J Sleep Res. 2012; 21: 163-169
        • Valko P.O.
        • Bassetti C.L.
        • Bloch K.E.
        • et al.
        Validation of the fatigue severity scale in a Swiss cohort.
        Sleep. 2008; 31: 1601-1607
        • Chabas D.
        • Foulon C.
        • Gonzalez J.
        • et al.
        Eating disorder and metabolism in narcoleptic patients.
        Sleep. 2007; 30: 1267-1273
        • Poryazova R.
        • Khatami R.
        • Werth E.
        • et al.
        Weak with sex: sexual intercourse as a trigger for cataplexy.
        J Sex Med. 2009; 6: 2271-2277
        • Broughton W.A.
        • Broughton R.J.
        Psychosocial impact of narcolepsy.
        Sleep. 1994; 17: S45-S49
        • Campbell A.J.
        • Signal T.L.
        • O'Keeffe K.M.
        • et al.
        Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life.
        N Z Med J. 2011; 124: 51-61
        • David A.
        • Constantino F.
        • Santos J.M.
        • et al.
        Health-related quality of life in Portuguese patients with narcolepsy.
        Sleep Med. 2012; 13: 273-277
        • Ervik S.
        • Abdelnoor M.
        • Heier M.S.
        • et al.
        Health-related quality of life in narcolepsy.
        Acta Neurol Scand. 2006; 114: 198-204
        • Vignatelli L.
        • D'Alessandro R.
        • Mosconi P.
        • et al.
        Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey.
        Sleep Med. 2004; 5: 467-475
        • Broughton R.J.
        • Guberman A.
        • Roberts J.
        Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.
        Epilepsia. 1984; 25: 423-433
        • Littner M.R.
        • Kushida C.
        • Wise M.
        • et al.
        Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.
        Sleep. 2005; 28: 113-121
        • Lammers G.J.
        • van Dijk J.G.
        The multiple sleep latency test: a paradoxical test?.
        Clin Neurol Neurosurg. 1992; 94: S108-S110
        • Aldrich M.S.
        • Chervin R.D.
        • Malow B.A.
        Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.
        Sleep. 1997; 20: 620-629
        • Bishop C.
        • Rosenthal L.
        • Helmus T.
        • et al.
        The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness.
        Sleep. 1996; 19: 727-730
        • Arii J.
        • Kanbayashi T.
        • Tanabe Y.
        • et al.
        CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.
        Neurology. 2004; 63: 2440-2442
        • Heier M.S.
        • Jansson T.S.
        • Gautvik K.M.
        Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
        J Clin Sleep Med. 2011; 7: 653-658
        • Kubota H.
        • Kanbayashi T.
        • Tanabe Y.
        • et al.
        Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
        Sleep. 2003; 26: 555-557
        • Tsukamoto H.
        • Ishikawa T.
        • Fujii Y.
        • et al.
        Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
        Neuropediatrics. 2002; 33: 51-52
        • Baumann C.R.
        • Bassetti C.L.
        Hypocretins (orexins) and sleep-wake disorders.
        Lancet Neurol. 2005; 4: 673-682
        • Lin L.
        • Bassetti C.
        • Lammers G.J.
        • et al.
        Guidelines for the appropriate use of CSF measurements to diagnose narcolepsy.
        in: Bassetti C. Billiard M. Mignot E. Narcolepsy and Hypersomnia. Informa Health Care, New York2007: 663-671
        • Marti I.
        • Valko P.O.
        • Khatami R.
        • et al.
        Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
        Sleep Med. 2009; 10: 1146-1150
        • Sadeh A.
        The role and validity of actigraphy in sleep medicine: an update.
        Sleep Med Rev. 2011; 15: 259-267
        • Aldrich M.S.
        The clinical spectrum of narcolepsy and idiopathic hypersomnia.
        Neurology. 1996; 46: 393-401
        • Silber M.H.
        • Krahn L.E.
        • Olson E.J.
        Diagnosing narcolepsy: validity and reliability of new diagnostic criteria.
        Sleep Med. 2002; 3: 109-113